Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma

doi:10.3748/wjg.v22.i25.5814

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8480)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

528

WORD

335

HTML

3736

Figures (1-3)

271

Tables (1-2)

213

Sum=5083

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1303

Download

2094

Sum=3397

Jul 7, 2016 (publication date) through Jan 17, 2025

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jul 7, 2016; 22(25): 5814-5821
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5814

Full Size Figure Download Figure

Figure 2 ARID1A mRNA level in intrahepatic cholangiocarcinoma patients. IHCC: Intrahepatic cholangiocarcinoma; PC: Paracarcinomatous; NL: Normal liver. ^cP < 0.001 vs PC and NL.

Citation: Yang SZ, Wang AQ, Du J, Wang JT, Yu WW, Liu Q, Wu YF, Chen SG. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. World J Gastroenterol 2016; 22(25): 5814-5821
URL: https://www.wjgnet.com/1007-9327/full/v22/i25/5814.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i25.5814